Hydration Pharmaceuticals Co. Ltd. ( (AU:HPC) ) has issued an announcement.
Hydration Pharmaceuticals Co. Ltd. has announced a correction to the issue date of shares under its Entitlement Offer. This update is part of a proposed non-renounceable pro rata issue of securities, which is intended to be quoted on the ASX. The correction ensures compliance with ASX listing rules and maintains transparency for stakeholders.
More about Hydration Pharmaceuticals Co. Ltd.
Hydration Pharmaceuticals Co. Ltd. operates in the pharmaceutical industry, focusing on hydration solutions. The company is involved in the development and distribution of products aimed at improving hydration and overall health, targeting both consumer and healthcare markets.
YTD Price Performance: -50.0%
Average Trading Volume: 414,691
Technical Sentiment Consensus Rating: Buy
See more data about HPC stock on TipRanks’ Stock Analysis page.